✦ LIBER ✦

Long-Term Outcome of Treatment With Protocols AL841, AL851, and ALHR88 in Children With Acute Lymphoblastic Leukemia: Results Obtained by the Kyushu-Yamaguchi Children’s Cancer Study Group

✍ Scribed by Akinobu Matsuzaki; Eiichi Ishii; Yoshihisa Nagatoshi; Haruhiko Eguchi; Hiroyuki Koga; Fumio Yanai; Hiroko Inada; Keiko Nibu; Yuji Tamai; Kensuke Akiyoshi; Hideki Nakayama; Toshiro Hara; Hiromichi Take; Sumio Miyazaki; Jun Okamura

Publisher: Carden Jennings Publishing
Year: 2001
Tongue: English
Weight: 109 KB
Volume: 73
Category: Article
ISSN: 0925-5710
DOI: 10.1007/bf02981964

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of high-risk acute lymphoblast

Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: A report from the Kyushu-Yamaguchi children cancer study group in Japan

✍ Matsuzaki, Akinobu; Ishii, Eiichi; Okamura, Jun; Eguchi, Haruhiko; Yoshida, Nobu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 770 KB

A total of 125 children, who were diagnosed as having high-risk acute lymphoblastic leukemia (ALL), were treated with two consecutive protocols designated as AL851 (1985( -1988( ) and ALHR88 (1988( -1990)). All patients received induction therapy consisting of vincristine (VCR), prednisolone (PSL),